Compagnie Lombard Odier SCmA’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.79M | Buy |
|
|||||
|
2025
Q1 | $3.66M | Buy |
|
|||||
|
2024
Q4 | $5M | Sell |
|
|||||
|
2024
Q3 | $8.57M | Sell |
|
|||||
|
2024
Q2 | $16.4M | Sell |
|
|||||
|
2024
Q1 | $14.8M | Buy |
|
|||||
|
2023
Q4 | $13.6M | Buy |
|
|||||
|
2023
Q3 | $13.4M | Buy |
|
|||||
|
2023
Q2 | $14.7M | Sell |
|
|||||
|
2023
Q1 | $18.7M | Buy |
|
|||||
|
2022
Q4 | $21.6M | Buy |
|
|||||
|
2022
Q3 | $13.7M | Sell |
|
|||||
|
2022
Q2 | $21.9M | Buy |
|
|||||
|
2022
Q1 | $26M | Buy |
|
|||||
|
2021
Q4 | $26.3M | Buy |
|
|||||
|
2021
Q3 | $34.2M | Buy |
|
|||||
|
2021
Q2 | $18.2M | Sell |
|
|||||
|
2021
Q1 | $21.2M | Buy |
|
|||||
|
2020
Q4 | $2.55M | Buy |
|
|||||
|
2020
Q3 | $686K | Buy |
|
|||||
|
2020
Q2 | $314K | Sell |
|
|||||
|
2020
Q1 | $271K | Buy |
|
|||||
|
2019
Q4 | – | Hold |
|